Influence of alpha- and beta-adrenoceptor antagonists on ventricular fibrillation in ischemic rat hearts

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 356, Issue 1, 1997, Pages 62-68

  Tölg, Ralph ^a   Kurz, Thomas ^a   Ungerer, Martin ^b   Schreieck, Jürgen ^b   Gorge, Bettina ^a   Richardt, Gert ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Adrenergic receptors; Alpha adrenoceptor subtypes; Arrhythmias; Myocardial ischemia; Rat heart

Indexed keywords

2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; 2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN; ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHLOROETHYLCLONIDINE; PHENTOLAMINE; PRAZOSIN; PROPRANOLOL; RECEPTOR SUBTYPE; TIMOLOL;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FIBRILLATION; ISOLATED HEART; MALE; NONHUMAN; RAT;

ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ELECTROCARDIOGRAPHY; MALE; MYOCARDIAL ISCHEMIA; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ADRENERGIC, ALPHA-2; VENTRICULAR FIBRILLATION;

EID: 0030972087     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005029     Document Type: Article

References (60)

1. Abendroth RR, Meesman W, Stephan K, Schley G, Hubner H (1977) Effect of the ß-blocking agent atenolol on arrhythmias, especially ventricular fibrillation and ventricular fibrillation threshold after acute experimental coronary artery occlusion. Z Kardiol 66: 341-350
2. Ablad B, Carlsson E, Ek L (1973) Pharmacological studies of two new cardioselective adrenergic beta-receptor antagonists. Life Sci 12: 107-119
3. Barrett AM, Cullum VA (1968) The biological properties of the optical isomers of propranolol and their effects on cardiac arrhythmias. Br J Pharmacol 34: 43-55
4. Benfey BG (1990) Function of myocardial α-adrenoceptors. Life Sci 46: 743-747
5. Benfey BG, Elfellah MS, Ogilvie RI, Varma DR (1984) Anti-arrhythmic effects of prazosin and propranolol during coronary artery occlusion and re-perfusion in dogs and pigs. Br J Pharmacol 82: 717-725
6. 1-adrenergic receptor antagonists on susceptibility to malignant arrhythmias: Protection from ventricular fibrillation. J Cardiovasc Pharmacol 24: 394-402
7. Bolli R, Fisher DJ, Taylor AA, Young JB, Miller RR (1984) Effect of a-adrenergic blockade on arrhythmias induced by myocardial ischemia and reperfusion in the dog. J Mol Cell Cardiol 16: 1101-1107
8. 1-adrenoceptors in the mammalian heart. J Cardiovasc Pharmacol 7: 791-798
9. 1-adrenergic receptor: activation of cyclic AMP degradation. J Biol Chem 260: 6733-6737
10. Buxton ILO, Brunton L (1986) a-Adrenergic receptors on rat ventricular myocytes: characteristics and linkage to cAMP metabolism. Am J Physiol 251: 307-313
11. Corbalan R, Verrier RL, Lown B (1976) Differing mechanisms for ventricular vulnerability during coronary artery occlusion and release. Am Heart J 92: 223-230
12. Corr PB, Penkoske PB, Sobel BE (1978) Adrenergic influences on arrhythmias due to coronary occlusion and reperfusion. Br Heart J 40 [suppl]: 62-70
13. Corr PB, Shayman JA, Kramer JB, Kipnis RJ (1981) Increased alpha-adrenergic receptors in ischemic cat myocardium: a potential mediator of electrophysiological derangements. J Clin Invest 67: 1232-1236
14. Corr PB, Yamada KA, Witkowski FX (1986) Mechanisms controlling cardiac autonomic function and their relation to arrhythmogenesis. In: Fozzard HA, Jennings RB, Katz AM, Morgan HE (eds) The Heart and Cardiovascular System, Scientific Foundations, Raven Press, New York, pp 1343-1403
15. Curtis MJ, Macleod BA, Walker MJA (1987) Models for the study of arrhythmias in myocardial ischemia and infarction: the use of the rat. J Mol Cell Cardiol 19: 399-419
16. Daugherty A, Frayn KN, Redfern WS, Woodward B (1986) The role of catecholamines in the production of ischaemia-induced ventricular arrhythmias in the rat in vivo and in vitro. Br J Pharmacol 87: 265-277
17. Daul A, Hermes U, Schafers RF, Wenzel R, von Birgelen C, Brodde OE (1995) The ß-adrenoceptor subtype(s) mediating adrenaline- and dobutamine-induced blood pressure and heart rate changes in healthy volunteers. Int J Clin Pharmacol Ther 32: 140-148
18. 1-adrenergic receptor subtypes modulate catecholamine-induced increases and decreases in ventricular automaticity. Circ Res 67: 1535-1551
19. Dietz R, Offner B, Dart AM, Schömig A (1989) Ischemia-induced noradrenaline release mediates ventricular arrhythmias. In: Brachmann J, Schömig A (eds) Adrenergic system and ventricular arrythmias in myocardial infarction. Springer, Berlin Heidelberg New York, pp 313-321
20. 1-adrenoceptors mediate positive inotropic effect and changes in phosphattdylinositol metabolism. Species differences in receptor distribution and the intracellular coupling process in mammalian ventricular myocardium. Circ Res 68: 1179-1190
21. Fitzgerald JD (1982) The effects of ß-adrenoceptor blocking drugs on early arrhythmias in experimental and clinical myocardial ischemia. In: Parratt JR (ed) Early Arrhythmias Resulting from Myocardial Ischemia. Macmillan, London, pp 295-316
22. Foo JW, Jowett A, Stafford A (1968) The effects of some beta-adrenoceptor blocking drugs on the uptake and release of noradrenaline by the heart. Br J Pharmacol 34: 141-147
23. Harris N, Kane KA, Parratt JR (1982) Autonomic and hormonal influences on the severity of coronary artery ligation induced arrhythmias in anaesthetized rats. Br J Pharmacol 77: 388P
24. Howe R, Shanks RG (1966) Optical isomers of propranolol. Nature 210: 1336-1338
25. ISIS-1 Collaborative Group (1988) Mechanisms tor the early mortality reduction produced by beta-blockade started early in acute myocardial infarction: ISIS-1. Lancet 1: 921-923
26. Jahnel U, Jakob H, Nawrath H (1992) Electrophysiologic and inotropic effects of α-adrenoceptor stimulation in human isolated atrial heart muscle. Naunyn-Schmiedeberg's Arch Pharmacol 346: 82-87
27. Kannengiesser GJ, Lubbe WF, Opie LH (1975) Experimental myocardial infarction with left ventricular failure in isolated perfused rat heart: Effects of isoproterenol and pacing. J Mol Cell Cardiol 7: 135-151
28. 1-adrenergic system and arrhythmias in ischemic heart disease. Eur Heart J 12 [Suppl. F]: 88-98
29. Kurz T, Offner B, Schreieck J, Richardt G, Tölg R, Schömig A (1995) Nonexocytotic noradrenaline release and ventricular fibrillation in ischemic rat hearts. Naunyn-Schmiedeberg's Arch Pharmacol 352: 491-496
30. Lee JH, Steinberg SF, Rosen MR (1991) A WB 4101-sensitive alpha-1 adrenergic receptor subtype modulates repolarization in canine Purkinje fibers. J Pharmacol Exp Ther 258: 681-687
31. Lindmar R, Muscholl E (1964) Die Wirkung von Pharmaka auf die Elimination von Noradrenalin aus der Perfusionsflüssigkeit und die Noradrenalinaufnahme in das isolierte Herz. Naunyn-Schmiedeberg's Arch exp Path Pharmacol 247: 469-492
32. Majid PA, Saxton C, Dykes JR, Galvin MC, Taylor SH (1970) Automatic control of insuline secretion and the treatment of heart failure. Br Med J 4: 320-323
33. Matthews JC, Baker JK (1982) Effects of propranolol and a number of its analogues on sodium channels. Biochem Pharmacol 31: 1681-1685
34. May GS (1983) A review of acute-phase beta-blocker trials in patients with myocardial infarction. Circulation 67: 121-125
35. 2+, Pharmacol Rev 40: 87-119
36. 1-adrenergic receptor subtype is responsible for delayed afterdepolarizations and triggered activity during simulated ischemia and reperfusion of isolated canine Purkinje fibers. Circulation 84: 1732-1740
37. 1 adrenergic receptors. Circulation 62: 111-149
38. Northover BJ (1983) A comparison of the electrophysiological actions of phentolamine with those of some other antiarrhythmic drugs on tissues isolated from the rat heart. Br J Pharmacol 80: 85-93
39. Opitz CF, Mitchell GF, Pfeffer MA, Pfeffer JM (1995) Arrhythmias and death after coronary artery occlusion in the rat. Circulation 92: 253-261
40. Parratt JR, Campbell C, Fagbemi O (1981) Catecholamines and early post-infarction arrhythmias. The effects of α- and ß-adrenoceptor blockade. In: Delius W, Gerlach E, Grobecker H, Kubier W (eds) Catecholamines and the heart. Springer, Berlin Heidelberg New York, pp 269-284
41. Perez O, Valenzuela C, Delpon E, Tamargo J (1994) Class I and III antiarrhythmic actions of prazosin in guinea-pig papillary muscle. Br J Pharmacol 111: 717-722
42. Pfister B, Imhof PR (1977) Inhibition of adrenaline-induced platelet aggregation by the orally administered alpha-adrenergic receptor blocker phentolamine (Regitine). Eur J Clin Pharmacol 11: 7-10
43. Richardt G, Lumpp U, Haass M, Schömig A (1990) Propranolol inhibits nonexocytotic noradrenaline release in myocardial ischemia. Naunyn-Schmiedeberg's Arch Pharmacol 341: 50-55
44. Rosen MR, Gelband H, Hoffmann BF (1971) Effects of phentolamine on electrophysiologic properties of isolated canine Purkinje fibers. J Pharmacol Exp Ther 179: 586-593
45. Rosen MR, Weiss MR, Danilo P Jr (1984) Effects of a-adrenergic agonists and blockers on Purkinje fibers transmembrane potentials and automaticity in dog. J Pharmacol Exp Ther 231: 566-571
46. + channels in Xenopus oocytes. Br J Pharmacol 107: 1061-1067
47. Schömig A, Dart AM, Dietz R, Mayer E, Kubier W (1984) Release of endogenous Catecholamines in the ischemic myocardium of the rat. Part A. locally mediated release. Circ Res 55: 689-701
48. Schömig A, Richardt G, Kurz T (1994) Sympatho-adrenergic activation of ischemic myocardium and ist arrhythmogenic impact. In: Zehender M, Meinertz T, Just H (eds) Myocardial Ischemia and Arrhythmia, Steinkopff Verlag, Darmstadt, pp. 117-143
49. Schömig A, Saman S, Beyer T, Dart AM, Offner B, Dietz R (1986) "Paradoxical" suppression of ventricular fibrillation by tricyclic antidepressants in myocardial ischemia. Circulation 74: II-341 A1358
50. Schumann HJ, Wagner J, Knorr A, Reidemeister JC, Sadony V, Schramm G (1978) Demonstration in human atrial preparations of α-adrenoceptors mediating positive inotropic effects. Naunyn-Schmiedeberg's Arch Pharmacol 302: 333-336
51. Scriabine A, Torchiana ML, Stavorski JM, Ludden CT, Minsker DH, Stone CA (1973) Some cardiovascular effects of timolol a new beta-adreneraic blocking agent. Arch Int Pharmacodyn 205: 76-93
52. Sharma A, Lee B, Saffitz B, Sobel B, Corr P (1983) Alpha adrenergic mediated accumulation of calcium in reperfused myocardium. J Clin Invest 72: 802-818
53. Sheridan DJ, Penkoske PA, Sobel BE, Corr PB (1980) Alpha adrenergic contributions to dysrhythmia during myocardial ischemia and reperfusion in cats. J Clin Invest 65: 161-171
54. Sommers HM, Jennings RB (1972) Ventricular fibrillation and myocardial necrosis after transient ischemia. Arch Intern Med 129: 790-789
55. 1-adrenoceptor densities in different mammalian species. Br J Pharmacol 107: 185-188
56. Stewart JR, Burmeister WE, Burmeister J, Lucchesi BR (1980) Electrophysiologic and antiarrhythmic effects of phentolamine in experimental coronary artery occlusion and reperfusion in the dog. J Cardiovasc Pharmacol 2: 77-91
57. 3H]-noradrenaline uptake by beta-adrenoceptor blocking drugs: influence of lipophilicity. Eur J Pharmacol 102: 315-324
58. Thandroyen FT, Worthington MG, Higginson L, Opie LH (1983) The effect of alpha-adrenoceptor antagonist agents on reperfusion ventricular fibrillation and metabolic status in the isolated perfused rat heart. J Am Coll Cardiol 1: 1056-1066
59. Werner U, Wagner J, Schumann HJ (1971) Beeinflussung der Noradrenalinabgabe aus isolierten Kaninchenherzen durch Beta-Adrenolytica unter sympathischer Nervenreizung. Naunyn-Schmiedeberg's Arch Pharmacol 268: 102-113
60. Winslow E (1984) Methods for the detection and assessment of antiarrhythmic activity. Pharmacol Ther 24: 401-433